[A contribution to the problem of dosage of cardiac glycosides after a change in glycoside preparation. Mathematical models of optimal dosage (author's transl)].

Suppr

超能文献

作者信息

Kratochvíl L, Lustig M

出版信息

Basic Res Cardiol. 1974 Nov-Dec;69(6):573-84. doi: 10.1007/BF01914493.

DOI:10.1007/BF01914493

PMID:4451545

Abstract

摘要

相似文献

[A contribution to the problem of dosage of cardiac glycosides after a change in glycoside preparation. Mathematical models of optimal dosage (author's transl)].

Basic Res Cardiol. 1974 Nov-Dec;69(6):573-84. doi: 10.1007/BF01914493.

Why Whip the Starving Horse When There Are Oats for the Starving Myocardium?当有燕麦可供饥饿的心肌使用时，为何还要鞭打饥饿的马匹？

Am J Ther. 2016 Sep-Oct;23(5):e1182-7. doi: 10.1097/MJT.0000000000000151.

[Some mathematical remarks on the problem of standardization of cardiac glycosides].[关于强心苷标准化问题的一些数学论述]

Arzneimittelforschung. 1967 Oct;17(10):1242-3.

[Concentration of cardiac glycosides in the heart and brain (author's transl)].心脏和大脑中强心苷的浓度（作者译）

Arzneimittelforschung. 1976;26(6):1213-6.

[Beta-acetyldigoxin and glycoside tolerance--clinical experiences].[β-乙酰地高辛与糖苷耐受性——临床经验]

Landarzt. 1968 Mar 31;44(9):425-34.

[Estimation of minimal lethal doses by infusion-toxicity and determination of the duration of action of cardiac glycosides].[通过输注毒性估计最小致死剂量及确定强心苷的作用持续时间]

Nihon Yakurigaku Zasshi. 1974 Jan;70(1):39-46. doi: 10.1254/fpj.70.39.

[Directed glycoside therapy of manifest heart insufficiency].[显性心力衰竭的定向糖苷治疗]

Med Klin. 1971 Apr 16;66(16):587-92.

[Differential treatment using cardiac glycosides].[使用强心苷的差异治疗]

Z Allgemeinmed. 1971 Aug 31;47(24):1215-9.

Digitalis pharmacokinetics and therapy with respect to impaired renal function.关于肾功能受损的洋地黄药代动力学及治疗

Klin Wochenschr. 1977 Jan 1;55(1):1-11. doi: 10.1007/BF01469777.

[Determination of cardiotoxicity of cardiac glycosides in the cat. II. Method of intravenous and intraduodenal infusion assay, planning, execution and evaluation of screening tests].[猫体内强心苷心脏毒性的测定。II. 静脉内和十二指肠内输注测定法、筛选试验的规划、实施及评估]

Arzneimittelforschung. 1970 Sep;20(9):1199-206.

引用本文的文献

[A slide ruler and nomogram for calculations in cumulation kinetics of cardiac glycosides (author's transl)].

Basic Res Cardiol. 1976 Mar-Apr;71(2):160-72. doi: 10.1007/BF01927868.

本文引用的文献

[Quantitative notes on the therapeutic use of cardiac glycosides. I. Variability of need and tolerance].[关于强心苷治疗用途的定量笔记。I.需求与耐受性的变异性]

Med Welt (Stuttg). 1951 Nov 24;20(47):1471-5.

[Pharmacodynamic principles of cardiac glycoside therapy].[强心苷治疗的药效学原理]

Ergeb Inn Med Kinderheilkd. 1954;5:457-552.

DISTRIBUTION IN PLASMA, UPTAKE BY THE HEART AND EXCRETION OF OUABAIN-H3 IN HUMAN SUBJECTS.哇巴因 - H3在人体血浆中的分布、心脏摄取及排泄情况

J Pharmacol Exp Ther. 1964 Sep;145:351-6.

DISTRIBUTION AND EXCRETION OF OUABAIN-H3 AND DIHYDRO-OUABAIN-H3 IN RATS AND SHEEP.哇巴因 - H3和二氢哇巴因 - H3在大鼠和绵羊体内的分布与排泄

J Pharmacol Exp Ther. 1963 Nov;142:223-30.

Tritiated digoxin studies in human subjects.人体受试者中的氚标记地高辛研究。

Arch Intern Med. 1961 Oct;108:531-9. doi: 10.1001/archinte.1961.03620100023004.

[Quantitative data on therapy with cardiac glycosides. II. The cumulation and damping of the effect].[强心苷治疗的定量数据。II. 效应的累积与衰减]

Klin Wochenschr. 1954 Oct 15;32(39-40):945-51. doi: 10.1007/BF01466987.

The distribution and concentration of tritiated digoxin in human tissues.氚标记地高辛在人体组织中的分布与浓度。

Ann Intern Med. 1967 Jan;66(1):116-24. doi: 10.7326/0003-4819-66-1-116.

New information regarding digitalis metabolism.关于洋地黄代谢的新信息。

Chest. 1971 Apr;59(4):433-7. doi: 10.1378/chest.59.4.433.

The excretion of tritiated digoxin in normal human volunteers before and after unilateral nephrectomy.单侧肾切除前后正常人类志愿者中氚标记地高辛的排泄情况。

Circulation. 1969 Oct;40(4):555-61. doi: 10.1161/01.cir.40.4.555.

The clinical pharmacology of digitalis glycosides: a review.洋地黄苷类的临床药理学：综述

Am J Med Sci. 1968 Jun;255:382-414. doi: 10.1097/00000441-196806000-00006.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验